April 26th 2024
Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Which Contraceptive Is Best for Women With Diabetes Mellitus?
May 15th 2013There is insufficient evidence to determine that hormonal contraceptives do not influence glucose and lipid metabolism in women with diabetes mellitus, concluded a systematic review conducted by the Cochrane Fertility Regulation Group.
Read More
Should All Women Freeze Their Eggs?
May 9th 2013"Should all women freeze their eggs?" This question was posed by Marcelle Cedars, MD, during a Tuesday afternoon session at ACOG's 61st annual clinical meeting. In a session offering late-breaking news from SGO, the Society for Maternal-Fetal Medicine (SMFM), the American Urogynecologic Society (AUGS), and the Society for Reproductive Endocrinology and Infertility (SREI), Dr. Cedars pointed out that as of October 2012, ASRM no longer considers egg freezing experimental.
Read More
Ob/Gyns Should Offer Long Acting Reversible Contraception First to Lower Unintended Pregnancy Rates
May 9th 2013The Contraceptive CHOICE Project, a research study at Washington University in St. Louis, found that offering long-acting, reversible contraception (LARC) to women first, citing its low-failure rates, reduced rates of unintended pregnancy and abortion and increased continuation rates.
Read More
Improving Uterine Artery Embolization Outcomes in Infertility Patients
May 9th 2013Uterine artery embolization for fibroids results in a tremendous reduction in menorrhagia. But while complication rates are low, up to 15% of patients are readmitted for indications like pain, bleeding and infection.
Read More
Improved Methods of Egg Preservation and Counseling Patients Seeking to Delay Conception
May 9th 2013In October 2012, the American Society of Reproductive Medicine announced it no longer considers oocyte freezing experimental. This raises complex questions about how to counsel patients who wish to preserve eggs for social indications.
Read More
Is Fertility Improved After Hysteroscopy for Uterine Cavity Abnormalities?
March 22nd 2013Hysteroscopic removal of polyps in women with unexplained infertility may increase their chances of becoming pregnant, concludes an intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.
Read More
Efficacy of Quick Start Hormonal Contraception
March 1st 2013Immediate start of hormonal contraception may reduce unintended pregnancies and increase method continuation, but the evidence is limited, according to the findings of an intervention review conducted by the Cochrane Fertility Regulation Group.
Read More
BRCA gene linked with early menopause
February 14th 2013A registry-based study by researchers at UC San Francisco (UCSF) has shown an association between BRCA1/2 mutations and early menopause. The findings, published in Cancer, suggest that women who carry the genetic defect may be at risk of earlier infertility.
Read More
The Most Hotly Anticipated Ob/Gyn Research of 2013
February 14th 2013New drugs, new research, new guidelines… there’s a lot for ob/gyns to look forward to in the coming year. Here, the leaders of seven ob/gyn societies share the most interesting, important, exciting things on their radar for 2013.
Read More
The Leadership Report: The Best Ob/Gyn Research From 2012
February 14th 2013From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.
Read More
IVF increases risk of blood clots during pregnancy
January 24th 2013A study published online by the British Medical Journal has shown that women who undergo in vitro fertilization (IVF) are at increased risk of pulmonary embolism (PE) and venous thromboembolism (VTE) during the first trimester.
Read More
Usefulness of SERMs for Uterine Fibroids Still Unestablished
November 28th 2012The available evidence that selective estrogen receptor modulators (SERMs) can reduce the size of fibroids or improve clinical symptoms is inconsistent, according to the results of an updated intervention review conducted by the Cochrane Menstrual Disorders and Subfertility Group.
Read More
Prophylactic Chemotherapy After Molar Pregnancy Is Unsupported
November 21st 2012The controversial practice of prophylactic chemotherapy to prevent gestational trophoblastic neoplasia (GTN) in women with hydatidiform mole, or molar pregnancy, is not recommended, according to the results of a recent intervention review.
Read More